Figure 5From: Long-term donepezil use for dementia with Lewy bodies: results from an open-label extension of Phase III trial Mean change in NPI-2 from baseline (FAS). NPI, Neuropsychiatric Inventory; FAS, full analysis set. (a)PLA-DON10 group started treatment with 3 mg at Week 16, and the dose was increased to 5 mg at Week 18. (b)PLA-DON10 and DON5-DON10 groups started treatment with 10 mg at Week 24 (dose decrease to 5 mg was allowed). *P < 0.05 (paired t test).Back to article page